Company Filing History:
Years Active: 2005
Title: **Victor P Pribluda: Innovator in Cellular Proliferation Inhibition**
Introduction
Victor P Pribluda is a distinguished inventor based in Silver Spring, MD, known for his innovative contributions to biomedical science. With a focus on therapies for diseases linked to abnormal cell proliferation, he has made significant strides in the field, particularly in cancer treatment.
Latest Patents
Victor P Pribluda holds a patent for "Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments." This patent addresses compositions that are effective in inhibiting undesirable cell proliferation, particularly endothelial cell growth and related angiogenesis. The invention encompasses natural and synthetic proteins, peptides, or fragments of proteinase inhibitors, such as Tissue Factor Pathway Inhibitor (TFPI). The methods described in the patent involve administering these compositions to humans or animals in sufficient doses to inhibit cell proliferation, with applications ranging from cancer treatment to controlling unwanted neovascularization.
Career Highlights
Victor's career highlights include his role at Entremed, Inc., where he is committed to advancing research and developing therapeutic strategies that target the complexities of cancer biology. His patent underscores a deep understanding of cellular mechanisms and therapeutic interventions, showcasing his dedication to improving patient outcomes in oncology.
Collaborations
Throughout his career, Victor has collaborated with esteemed colleagues such as Todd Hembrough and Adonia E Papathanassiu. These partnerships reflect a shared vision for innovative research and a collective effort to translate scientific discoveries into viable treatments that address critical health challenges.
Conclusion
With his patent and ongoing research efforts at Entremed, Inc., Victor P Pribluda exemplifies the spirit of innovation needed in the fight against cancer. His contributions to the field not only enhance our understanding of cellular proliferation but also pave the way for new therapeutic approaches that hold promise for patients battling this disease.